Skip to content

Clinical trials

Withdrawn Phase 3 Respiratory Distress Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 3 Status: Withdrawn Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20202
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
APR Applied Pharma Research s.a.1
Alung Technologies1
ImmunityBio, Inc.1
London School of Hygiene and Tropical Medicine1
Negovsky Reanimatology Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome5
COVID-192
Acute Lung Injury1
Asthma1
Community-Acquired Pneumonia1
Critical Illness1
Dyspnea1
Emphysema1
Heart Failure1
Lymphopenia1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.